Content by Temple University Health System
|3 min read
Blood Test Predicts Which Bladder Cancer Patients May Safely Skip Surgery
Positive results from the RETAIN-2 trial demonstrate that a response-adapted bladder-preservation approach involving neoadjuvant chemoimmunotherapy can be considered in select patients
|2 min read
Clinical Trial of Gimsilumab for COVID-19 Patients Underway
Gimsilumab is a fully human monoclonal antibody targeting granulocyte macrophage-colony stimulating factor, which is believed to be a key driver of lung hyper-inflammation
|3 min read
New Immunotherapeutic Strategy Shows Promise in Eradicating Infectious Biofilms
Communities of bacteria known as biofilms are notorious for forming on implanted medical devices and tissues in the body, where they give rise to chronic, sometimes life-threatening infections
|2 min read
Embryonic MicroRNA Fuels Heart Cell Regeneration
A new study found that by adulthood, the heart is no longer able to replenish injured or diseased cellsPage 1 of 1
